Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndrome
US11471476B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2017 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Sep 12, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are microRNA from a rhodiola root and uses thereof in the prevention and/or the treatment of a fibroplasia medical sign and/or syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.